Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors. | Ann Med | 2023 | 37092854 | PubTator, text mining | PubMed |
| Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma. | Front Med (Lausanne) | 2023 | 37081847 | PubTator, text mining | PubMed |
| Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification. | J Proteome Res | 2023 | 37071664 | PubTator, text mining | PubMed |
| DNA Damage-Mediated Neurotoxicity in Parkinson's Disease. | Int J Mol Sci | 2023 | 37047285 | PubTator, text mining | PubMed |
| Drug cytotoxicity screening using human intestinal organoids propagated with extensive cost-reduction strategies. | Sci Rep | 2023 | 37012293 | PubTator, text mining | PubMed |
| Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers. | NPJ Breast Cancer | 2023 | 36997566 | PubTator, text mining | PubMed |
| Importance of Germline and Somatic Alterations in Human MRE11, RAD50, and NBN Genes Coding for MRN Complex. | Int J Mol Sci | 2023 | 36982687 | PubTator, text mining | PubMed |
| 8-Oxoguanine DNA Glycosylase 1 Upregulation as a Risk Factor for Obesity and Colorectal Cancer. | Int J Mol Sci | 2023 | 36982562 | PubTator, text mining | PubMed |
| Genetic Networks of Alzheimer's Disease, Aging, and Longevity in Humans. | Int J Mol Sci | 2023 | 36982253 | PubTator, text mining | PubMed |
| DNA Repair and Therapeutic Strategies in Cancer Stem Cells. | Cancers (Basel) | 2023 | 36980782 | PubTator, text mining | PubMed |
| Novel Insights into RAD52's Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies. | Cancers (Basel) | 2023 | 36980703 | PubTator, text mining | PubMed |
| Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1. | Front Endocrinol (Lausanne) | 2023 | 36967793 | PubTator, text mining | PubMed |
| Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration. | NPJ Precis Oncol | 2023 | 36964191 | PubTator, text mining | PubMed |
| RecQ dysfunction contributes to social and depressive-like behavior and affects aldolase activity in mice. | Neurobiol Dis | 2023 | 36948261 | PubTator, text mining | PubMed |
| Specific gene expression signatures of low grade meningiomas. | Front Oncol | 2023 | 36937440 | PubTator, text mining | PubMed |
| Influence of methyl donor nutrients as epigenetic regulators in colorectal cancer: A systematic review of observational studies. | World J Gastroenterol | 2023 | 36926668 | PubTator, text mining | PubMed |
| Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma. | Nat Commun | 2023 | 36922497 | PubTator, text mining | PubMed |
| Recent progress in targeted therapy for non-small cell lung cancer. | Front Pharmacol | 2023 | 36909198 | PubTator, text mining | PubMed |
| DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy. | Cancers (Basel) | 2023 | 36900418 | PubTator, text mining | PubMed |
| MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles. | iScience | 2023 | 36879816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=18